Viewing Study NCT06175494


Ignite Creation Date: 2025-12-25 @ 1:35 AM
Ignite Modification Date: 2025-12-25 @ 11:49 PM
Study NCT ID: NCT06175494
Status: RECRUITING
Last Update Posted: 2024-04-23
First Post: 2023-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
Sponsor: WestVac Biopharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module